4th Annual Genome Editing USA Congress
April 7 - 8, 2020 - GBOxford Global
b.copeman@oxfordglobal.co.uk
Phone:+44 (0)1865 248455
Fax:+44 (0)1865 689120
350+ end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical & biotech companies.3 outstanding programmes bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis, Genome Editing.80+ case studies, solution & technology presentations & 2 interactive workshops over the 2 days.07 April 2019 – Day One• Genome Editing Technologies & Techniques• Drug Discovery & Development Applications in In Vivo Therapeutics08 April 2019 – Day Two• Drug Discovery & Development – Target Identification and Validation• Non-Human Models in Diagnostics & TherapeuticsView Agenda: http://bit.ly/2rLMzeL 2020 Live WebinarChemically-Modified Polynucleotides for Inhibiting, Expressing and Repairing Nucleic Acids: Then & NowPresented by Tod Woolf, Founder & CEO, ETAGEN Pharma, Inc.Tuesday, 10 March 2020 | 03:30 PM GMTRegister: https://bit.ly/2QvO7Us